4//SEC Filing
Price David 4
Accession 0001562180-19-003661
CIK 0001314102other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:49 PM ET
Size
5.6 KB
Accession
0001562180-19-003661
Insider Transaction Report
Form 4
Price David
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-06-25+300,000→ 300,000 totalExercise: $2.65Exp: 2029-02-21→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 21, 2019
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001449336
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:49 PM ET
- Size
- 5.6 KB